Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patient groups:
- Adults aged 18 or older who have been diagnosed with COPD (a lung disease) of any severity, are non-smokers (meaning they have smoked fewer than 100 cigarettes total in their lifetime and do not currently smoke), and are enrolled at the Pneumology Department in Bologna
- Adults aged 18 or older who have been diagnosed with any type or stage of lung cancer, are non-smokers by the same definition, and are enrolled at the Medical Oncology Department in Bologna
- Adults aged 18 or older who have been diagnosed with any type of leukemia (a blood cancer), are non-smokers by the same definition, and are enrolled at the Hematology Department in Foggia
Healthy volunteer groups:
- Adults aged 18 or older who are non-smokers, have no personal history of COPD, solid tumours, or leukemia, and are employees of one of the participating hospitals (Bologna or Foggia)
- All participants in every group must sign an informed consent form agreeing to take part
Who may not be able to join:
COPD patient group (Bologna):
- People with a condition called alpha-1 antitrypsin deficiency (a genetic disorder affecting the lungs and liver)
Lung cancer patient group (Bologna):
- People who have a previous or current diagnosis of other solid tumours, myelodysplastic syndromes, or myeloproliferative neoplasms (certain blood or bone marrow conditions)
- People who have previously received or are currently receiving cancer treatment (anti-cancer drugs)
Leukemia patient group (Foggia):
- People who have previously been diagnosed with solid tumours, myelodysplastic syndromes, or myeloproliferative neoplasms
- People who have previously been treated with specific cancer-related medications, including alkylating agents, hydroxyurea, topoisomerase II inhibitors, or lenalidomide
- People with certain pre-existing genetic conditions, including Fanconi anaemia, ataxia-telangiectasia, Down syndrome, xeroderma pigmentosum, or Li-Fraumeni syndrome
- People with an active infection of HIV, human T-lymphotropic virus (types 1 or 2), or Epstein-Barr virus
Healthy volunteer groups (all sites):
- Employees who work specifically within the same department running the trial at their respective hospital are not eligible to join as healthy volunteers at that department
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stefano Nava, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: +39 0512143253
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of pollutants in biological samples; Identification of pollutants in biological samples; Identification of pollutants in biological samples; Identification of pollutants in biological samples; Identification of pollutants in biological samples; Identification of pollutants in biological samples
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.